Therefore, despite SIRT7 appearing to be involved in maintaining a tumourigeneic phenotype in perhaps breast or thyroid cancer, it has also the potential to possess anti-tumourigenic properties in pancreatic cancer. This evidence concerns the gene SIRT7 and familial pancreatic carcinoma.